EMSculpt NEO West Edmonton

EMSculpt NEO is a non-invasive body contouring treatment that combines radiofrequency energy and high-intensity focused electromagnetic (HIFEM) technology in a single session. This dual-action approach simultaneously targets fat reduction and muscle strengthening, making it suitable for areas such as the abdomen, buttocks, arms and thighs.

Book an Appointment

Because every patient's body composition, goals and medical history are different, EMSculpt NEO at our Dermapure West Edmonton clinic always begins with a personalized consultation. Together with your specialist, you will assess whether EMSculpt NEO is the most appropriate option for your body and your goals and discuss what a realistic treatment plan could look like, the expected results and the possible side effects, which will be reviewed in detail during your consultation.

What to Expect During Your Session

Step 1

Personalized Assessment

Our expert will meet with you during your personalized assessment to better understand your goals and determine a treatment plan.

Step 2

Review & Consent

Prior to your treatment, our team will review our consent forms with you and answer any questions you may have.

Step 3

Begin Treatment

Your treatment provider will focus the handheld device on the desired area during your treatment sessions. You may feel a heating sensation that is often well-tolerated. Muscle tightness is also common and subsides once the 30-minute session is complete.

Step 4

After Treatment

Once your EMSculpt Neo treatment is complete, you can resume your normal activities.

Follow-Up & Maintenance

EMSculpt Neo effects can be seen immediately following a series of four treatment sessions and will continue to develop over two to four weeks. Patients will see the best results within eight to 12 weeks after their final treatment session.

Contraindications

We do not perform EMSculpt Neo treatments on patients who have cardiovascular disease, metal implants, drug pumps, hernias, epilepsy, pulmonary insufficiency, hemorrhagic conditions, have recently had surgery, or have a malignant tumor. Additionally, those who are pregnant, breastfeeding, or menstruating should refrain from this treatment.